Skip to main content

The $1.6 Billion SBIR Money Bus: Coming to a Town Near You

NEW YORK, July 24 - Hoping to help fund new life-science technology companies in the United States, representatives from the US National Institutes of Health and other federal agencies will be making stops at six northwestern towns to look for companies eligible for SBIR and STTR grants totaling $1.6 billion.


Officials will head to the following cities to hold one-on-one discussions with business owners, entrepreneurs, scientists, and researchers about how to apply for these grants:


·        Sept. 18--Boise, Idaho; Idaho Small Business Development Center

·        Sept. 19--Salt Lake City; Utah Centers of Excellence Program

·        Sept. 22--Reno, NV; NSBDC, Nevada Commission on Economic Development

·        Sept. 23--Sacramento, Calif.; Golden Capital Network, SARTA

·        Sept. 24--Portland, Ore.; Oregon Economic & Community Development Department

·        Sept. 25--Seattle; Washington Technology Center


"With technology advancing at a rapid rate and uncertain economic conditions, it is essential that we promote Federal funding opportunities to small businesses across the country--particularly in the Northwest, to help them stay competitive," Jo Anne Goodnight, SBIR/STTR program manager at NIH, said in a statement.

R&D program managers for one-on-one chats from the following agencies will be present: Department of Health and Human Services; National Science Foundation; Department of Education; Department of Defense's Defense Advanced Research Projects Agency, Special Operations Command, National Imagery and Mapping Agency, Departments of the Army, Navy, and Air Force; Department of Transportation; Department of Commerce; Environmental Protection Agency; NASA,  and Department of Energy.

The SBIR and STTR programs issue awards to US companies with 500 or fewer employees for R&D projects that have "commercialization potential in the private and/or public sector," according to the statement.

Click here for more information on SBIR and STTR awards.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.